WeRide outlined plans to commercialize its L4 AV portfolio in Slovakia during a meeting with His Excellency Mr. Robert Fico Prime Minister of Slovakia.
WUHU, China, June 09, 2026 (GLOBE NEWSWIRE) -- The winners of the 47th Telly Awards were officially announced. Return of the Cheetah: Horn of Africa, a public welfare documentary co-produced by JETOUR and DISCOVERY Channel, received three major honors, including Gold Winner in General-Documentary: Short Form, Silver Winner in Craft-Videography & Cinematography, and Silver Winner in General-Nature & Wildlife. The film also won a Gold Tower Award at the New York Festivals Advertising Awards, earning international recognition for its outstanding production quality and commitment to wildlife conservation.
NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. (NASDAQ: MANH).
SEOUL, South Korea, June 9, 2026 /PRNewswire/ -- MegazoneCloud, announced today that it was named the 2026 Datadog Partner Network (DPN) Partner of the Year...
Peer-nominated award honors leaders who exemplify community impact and a commitment to changing the odds for kids across California.SANTA ANA, Calif., June 9, 2026...
Sparking curiosity among underprivileged students through hands-on STEM education.SAN FRANCISCO, June 9, 2026 /PRNewswire/ -- STEM education has become an increasingly important part of...
MYRTLE BEACH, S.C., June 9, 2026 /PRNewswire/ -- Prominently featured in The Inner Circle, Dr. Susan Blyskal is acknowledged as a Pinnacle Professional Member Inner Circle...
NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today announced that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to lasmecabtagene timgedleucel (lasme-cel), its CD22-targeting allogeneic CAR-T cell therapy product candidate, for the treatment of patients with relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-ALL).
Milestone reflects company's transformation and consistent performanceAUSTIN, Texas, June 9, 2026 /PRNewswire/ -- Flex (NASDAQ: FLEX) today announced it has been selected to join the...
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Wise Group plc (NASDAQ: WSE) resulting from allegations that Wise Group plc may have issued materially misleading business information to the investing public.
Recognition highlights the impact of OPUS, the Orchestration Platform for Universal Solutions, in helping life sciences and healthcare companies digitalize multienterprise transactions and processes...